TearLab (TearLab) Days Sales Outstanding : 16.61 (As of Mar. 2020)

View and export this data going back to 2004. Start your Free Trial

What is TearLab Days Sales Outstanding?

TearLab's average Accounts Receivable for the three months ended in Mar. 2020 was $0.93 Mil. TearLab's Revenue for the three months ended in Mar. 2020 was $5.09 Mil. Hence, TearLab's Days Sales Outstanding for the three months ended in Mar. 2020 was 16.61.

The historical rank and industry rank for TearLab's Days Sales Outstanding or its related term are showing as below:

TEAR's Days Sales Outstanding is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 69.24
* Ranked among companies with meaningful Days Sales Outstanding only.

TearLab's Days Sales Outstanding declined from Mar. 2019 (18.34) to Mar. 2020 (16.61).

TearLab Days Sales Outstanding Historical Data

The historical data trend for TearLab's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TearLab Days Sales Outstanding Chart

TearLab Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Days Sales Outstanding

Get a 7-Day Free Trial

39.91

34.53

25.67

19.87

16.94

TearLab Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
Days Sales Outstanding	Get a 7-Day Free Trial															18.34	17.32	17.03	15.74	16.61

Competitive Comparison of TearLab's Days Sales Outstanding

For the Diagnostics & Research subindustry, TearLab's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TearLab's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, TearLab's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where TearLab's Days Sales Outstanding falls into.

TearLab Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

TearLab's Days Sales Outstanding for the fiscal year that ended in Dec. 2019 is calculated as

	Days Sales Outstanding (A: Dec. 2019 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2018 )	+	Accounts Receivable (A: Dec. 2019 ))	/	count )	/	Revenue (A: Dec. 2019 )	*	Days in Period
=	( (1.186	+	0.917)	/	2 )	/	22.655	*	365
=	1.0515					/	22.655	*	365
=	16.94

TearLab's Days Sales Outstanding for the quarter that ended in Mar. 2020 is calculated as:

	Days Sales Outstanding (Q: Mar. 2020 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2019 )	+	Accounts Receivable (A: Mar. 2020 ))	/	count )	/	Revenue (A: Mar. 2020 )	*	Days in Period
=	( (0.917	+	0.936)	/	2 )	/	5.091	*	365 / 4
=	0.9265					/	5.091	*	365 / 4
=	16.61

TearLab (OTCPK:TEAR) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

TearLab Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of TearLab's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

TearLab (TearLab) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » TearLab Corp (OTCPK:TEAR) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 LaTerraza Boulevard, SuiteÂ 101, Escondido, CA, USA, 92025

Website

http://www.tearlab.com

TearLab Corp is a part of the diagnostic industry. It is an in-vitro diagnostic company based in the United States. TearLab has commercialized a proprietary tear testing platform, the TearLab Osmolarity System that enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The company operates through its wholly-owned subsidiary, TearLab Research Inc. Most of the company's revenue is derived from the United States region.

Executives

Anthony E Altig	director	C/O OPTIMER PHARMACEUTICALS, INC, 101 HUDSON STREET, JERSEY CITY NJ 07302
Cr Group L.p.	10 percent owner	1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Lindstrom Richard L Md	director	2811 WESTWOOD PL, WAYZATA MN 55391
Awm Investment Company, Inc.	10 percent owner	527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Adrienne L Graves	director	125 STONE MOUNTAIN CIRCLE, NAPA CA 94558
Gilbert S Omenn	director	AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
John Y Caloz	officer: Chief Financial Officer	ETON AVE, C/O INTERNATIONAL REMOTE IMAGING SYS, CHATSWORTH CA 91311